Kadinfection prevention and control guideline for cystic fibrosis: 2013 update

Lisa Saiman; Jane D. Siegel; John J. LiPuma; Rebekah F. Brown; Elizabeth A. Bryson; Mary Jo Chambers; Veronica S. Downer; Jill Fliege; Leslie A. Hazle; Manu Jain; Bruce C. Marshall; Catherine O'Malley; Suzanne R. Pattee; Gail Potter-Bynoe; Siobhan Reid; Karen A. Robinson; Kathryn A. Sabadosa; H. Joel Schmidt; Elizabeth Tullis; Jennifer Webber; David J. Weber

doi:10.1086/676882

Kadinfection prevention and control guideline for cystic fibrosis: 2013 update

Lisa Saiman, Jane D. Siegel, John J. LiPuma, Rebekah F. Brown, Elizabeth A. Bryson, Mary Jo Chambers, Veronica S. Downer, Jill Fliege, Leslie A. Hazle, Manu Jain, Bruce C. Marshall, Catherine O'Malley, Suzanne R. Pattee, Gail Potter-Bynoe, Siobhan Reid, Karen A. Robinson, Kathryn A. Sabadosa, H. Joel Schmidt, Elizabeth Tullis, Jennifer WebberDavid J. Weber

Research output: Contribution to journal › Article › peer-review

218 Scopus citations

Abstract

In summary, epidemiologic studies have shown that pathogens, other than Burkholderia spp., can be transmitted among individuals with CF, resulting in adverse clinical outcomes, including increased morbidity and mortality. The updated guideline is a response to new knowledge and new challenges in both IP&C and CF. The primary objective of the guideline is to provide recommendations to reduce the risk of transmission and acquisition of CF pathogens by individuals with CF and to provide a more comprehensive understanding of effective strategies to optimize safety for this unique population.

Original language	English (US)
Pages (from-to)	S1-S67
Journal	Infection control and hospital epidemiology
Volume	35
Issue number	SUPPL.1
DOIs	https://doi.org/10.1086/676882
State	Published - Aug 2014
Externally published	Yes

ASJC Scopus subject areas

Epidemiology
Microbiology (medical)
Infectious Diseases

Access to Document

10.1086/676882

Cite this

Saiman, L., Siegel, J. D., LiPuma, J. J., Brown, R. F., Bryson, E. A., Chambers, M. J., Downer, V. S., Fliege, J., Hazle, L. A., Jain, M., Marshall, B. C., O'Malley, C., Pattee, S. R., Potter-Bynoe, G., Reid, S., Robinson, K. A., Sabadosa, K. A., Schmidt, H. J., Tullis, E., ... Weber, D. J. (2014). Kadinfection prevention and control guideline for cystic fibrosis: 2013 update. Infection control and hospital epidemiology, 35(SUPPL.1), S1-S67. https://doi.org/10.1086/676882

Saiman, L, Siegel, JD, LiPuma, JJ, Brown, RF, Bryson, EA, Chambers, MJ, Downer, VS, Fliege, J, Hazle, LA, Jain, M, Marshall, BC, O'Malley, C, Pattee, SR, Potter-Bynoe, G, Reid, S, Robinson, KA, Sabadosa, KA, Schmidt, HJ, Tullis, E, Webber, J & Weber, DJ 2014, 'Kadinfection prevention and control guideline for cystic fibrosis: 2013 update', Infection control and hospital epidemiology, vol. 35, no. SUPPL.1, pp. S1-S67. https://doi.org/10.1086/676882

@article{dbe866a22e494030913ffe3acefca597,

title = "Kadinfection prevention and control guideline for cystic fibrosis: 2013 update",

abstract = "In summary, epidemiologic studies have shown that pathogens, other than Burkholderia spp., can be transmitted among individuals with CF, resulting in adverse clinical outcomes, including increased morbidity and mortality. The updated guideline is a response to new knowledge and new challenges in both IP&C and CF. The primary objective of the guideline is to provide recommendations to reduce the risk of transmission and acquisition of CF pathogens by individuals with CF and to provide a more comprehensive understanding of effective strategies to optimize safety for this unique population.",

author = "Lisa Saiman and Siegel, {Jane D.} and LiPuma, {John J.} and Brown, {Rebekah F.} and Bryson, {Elizabeth A.} and Chambers, {Mary Jo} and Downer, {Veronica S.} and Jill Fliege and Hazle, {Leslie A.} and Manu Jain and Marshall, {Bruce C.} and Catherine O'Malley and Pattee, {Suzanne R.} and Gail Potter-Bynoe and Siobhan Reid and Robinson, {Karen A.} and Sabadosa, {Kathryn A.} and Schmidt, {H. Joel} and Elizabeth Tullis and Jennifer Webber and Weber, {David J.}",

year = "2014",

month = aug,

doi = "10.1086/676882",

language = "English (US)",

volume = "35",

pages = "S1--S67",

journal = "Infection control and hospital epidemiology",

issn = "0899-823X",

publisher = "University of Chicago Press",

number = "SUPPL.1",

}

TY - JOUR

T1 - Kadinfection prevention and control guideline for cystic fibrosis

T2 - 2013 update

AU - Saiman, Lisa

AU - Siegel, Jane D.

AU - LiPuma, John J.

AU - Brown, Rebekah F.

AU - Bryson, Elizabeth A.

AU - Chambers, Mary Jo

AU - Downer, Veronica S.

AU - Fliege, Jill

AU - Hazle, Leslie A.

AU - Jain, Manu

AU - Marshall, Bruce C.

AU - O'Malley, Catherine

AU - Pattee, Suzanne R.

AU - Potter-Bynoe, Gail

AU - Reid, Siobhan

AU - Robinson, Karen A.

AU - Sabadosa, Kathryn A.

AU - Schmidt, H. Joel

AU - Tullis, Elizabeth

AU - Webber, Jennifer

AU - Weber, David J.

PY - 2014/8

Y1 - 2014/8

N2 - In summary, epidemiologic studies have shown that pathogens, other than Burkholderia spp., can be transmitted among individuals with CF, resulting in adverse clinical outcomes, including increased morbidity and mortality. The updated guideline is a response to new knowledge and new challenges in both IP&C and CF. The primary objective of the guideline is to provide recommendations to reduce the risk of transmission and acquisition of CF pathogens by individuals with CF and to provide a more comprehensive understanding of effective strategies to optimize safety for this unique population.

AB - In summary, epidemiologic studies have shown that pathogens, other than Burkholderia spp., can be transmitted among individuals with CF, resulting in adverse clinical outcomes, including increased morbidity and mortality. The updated guideline is a response to new knowledge and new challenges in both IP&C and CF. The primary objective of the guideline is to provide recommendations to reduce the risk of transmission and acquisition of CF pathogens by individuals with CF and to provide a more comprehensive understanding of effective strategies to optimize safety for this unique population.

UR - http://www.scopus.com/inward/record.url?scp=84904424764&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84904424764&partnerID=8YFLogxK

U2 - 10.1086/676882

DO - 10.1086/676882

M3 - Article

C2 - 25025126

AN - SCOPUS:84904424764

SN - 0899-823X

VL - 35

SP - S1-S67

JO - Infection control and hospital epidemiology

JF - Infection control and hospital epidemiology

IS - SUPPL.1

ER -

Kadinfection prevention and control guideline for cystic fibrosis: 2013 update

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this